Vrisha Shah: Exploring Transgenic Mouse Models for Pregnancy Outcomes at ISTH 2026
Vrisha Shah, MSc Candidate in Anatomical Sciences, Researcher in Platelet-type von Willebrand Disease and Adverse Pregnancy Outcomes, shared a post on LinkedIn:
“Attending the International Society on Thrombosis and Haemostasis (ISTH) Congress 2026 in Paris was an incredible opportunity to present my research and connect with researchers from around the world.
My poster explored how platelet GPIbα dysfunction influences placental development and pregnancy outcomes using transgenic mouse models, with the goal of better understanding the role of platelet dysfunction in abnormal placental structure and adverse pregnancy outcomes.
Presenting this work led to thoughtful discussions and valuable feedback that will help guide the next steps of the project.
Beyond presenting my research, the congress was an inspiring opportunity to learn from experts in thrombosis, hemostasis, and vascular biology, discover the latest advances in the field, and gain new perspectives on translational research and scientific collaboration.
A special thank you to my supervisor, Dr. Maha Othman, for her mentorship, encouragement, and continued support. This experience would not have been possible without her guidance, and I am truly grateful for the opportunity to contribute to this research.
Thank you as well to everyone who stopped by my poster, asked thoughtful questions, and shared their insights.
I’m excited to continue building on this work as I begin my MSc in Anatomical Sciences at Queen’s University.”
Stay updated with Hemostasis Today.
-
Sep 11, 2026, 15:34Dhargam Aljebouri: A New Milestone for Transfusion Education in Iraq
-
Sep 11, 2026, 15:17Shadi Tabibian: Where Laboratory Precision Meets Clinical Care
-
Sep 11, 2026, 14:58Kevin Land: Connecting Donors to Patients Across the Spectrum of Care
-
Sep 11, 2026, 14:45Jorge Mascaro: The Growing Impact of the UK Aortic Society on Aortic Disease Care
-
Sep 11, 2026, 14:31Hany Ibrahim: Lp(a) Lowering Meets a Critical Test in the Lp(a)HORIZON Trial
-
Sep 11, 2026, 13:35How Non-Factor Therapies Are Changing Hemophilia Care – Seminars in Thrombosis and Hemostasis
-
Sep 11, 2026, 13:21Emmanuel J Favaloro: Rethinking Quality Control in VWD Testing
-
Sep 11, 2026, 13:10Tessa Youngner: New Free E-Course Introduces Comprehensive SCD Care
-
Sep 11, 2026, 12:55Identifying Key Research Priorities for VTE and Stroke – International Journal of Stroke